Pahnke’s ‘Good Friday Experiment’: a long-term follow-up and methodological critique

The original Good Friday experiment was designed as a randomised, matched-group, double-blind study using an active placebo. Twenty white male Protestant divinity students from the same theological school were paired on characteristics such as prior religious experience and psychological profile to form ten matched pairs. On the morning of the service a coin flip assigned each member of a pair to receive either psilocybin (30 mg) or an active placebo (nicotinic acid). The research team placed the session within the context of an actual Good Friday church service broadcast into a basement chapel to foster a supportive, ritual-like environment. Measures included a 147-item questionnaire given one to two days after the session, a 100-item follow-up questionnaire at six months, three tape-recorded interviews (immediate, several days, and six months post-session), and content-analysed written accounts. Pahnke developed an eight-category typology of mystical experience (unity; transcendence of time and space; sacredness; sense of objective reality; deeply felt positive mood; ineffability; paradoxicality; transiency). Independent raters trained in content analysis scored interview transcripts and written reports. Responses were converted into percentage scores relative to maximum possible scores for each category and aggregated into three complementary measures. Doblin's long-term follow-up involved extensive archival work and participant tracing: 19 of the original 20 subjects were identified, and 16 were tape-recorded and interviewed (15 in person, 1 by telephone). Those 16 also completed the six-month questionnaire used originally; among them were nine controls and seven experimental subjects. Three original psilocybin subjects did not provide long-term questionnaire data (one deceased, one unlocated, one declined). Informal interviews were also conducted with seven of Pahnke's original research assistants. The extracted text does not provide detailed information about the statistical tests beyond reporting significance at p<.05 for group differences in questionnaire scores.

Doblin's follow-up found durable differences between the original psilocybin and control groups on the questionnaire measures and consistent qualitative reports from experimental subjects. On Pahnke's aggregated mystical-category score, the experimental group's mean was 60.8% at six months and increased to 66.8% at the long-term follow-up. The control group's mean was 11.8% at six months and 12.2% at long-term. Differences between groups were reported as statistically significant at p<.05 for every category at long-term follow-up. The experimental group scored highest in categories associated with altered states (transcendence of time and space, ineffability, transiency); the control group scored relatively higher on categories a religious service typically induces (sacredness, positive mood, sense of objectivity/reality). Qualitative interviews with 16 subjects reinforced these numeric findings. All interviewed psilocybin subjects recalled vivid portions of their Good Friday experience and described elements they judged to be genuinely mystical; many characterised the session as one of the high points of their spiritual life. Several reported that the drug-facilitated experiences were more intense, and included a wider emotional range (including fear or agony), than their non-drug mystical experiences. Reported long-term positive effects among experimental subjects included increased appreciation of life and nature, deeper joy, strengthened vocational and spiritual commitments, increased tolerance toward others, reduced fear of death, and increased political engagement for some. By contrast, controls generally recalled few details and reported little or no persisting positive change; one control reported that the session convinced him not to take psychedelics. The follow-up also surfaced important methodological and safety issues. The original double-blind was broken during the service: nicotinic acid produced transient somatic symptoms that initially mimicked drug effects for some controls, but as psilocybin effects deepened the blind was inevitably lost and by the end of the day all subjects correctly identified their condition. Doblin therefore notes that the study cannot disaggregate the relative contributions of psilocybin and suggestion in producing the reported experiences. In addition, several psilocybin subjects experienced intense psychological struggles during the session; one subject reportedly received an intramuscular injection of the tranquiliser thorazine during the experiment — an event that Pahnke did not disclose in his thesis. That subject later described only "slightly harmful" persisting effects at six months, and second‑hand reports during the long-term follow-up suggested no enduring dysfunction. Doblin cautions that missing long-term data from three psilocybin participants (including one who declined participation and the deceased subject) may somewhat overstate the experimental group's averaged long-term scores.

Doblin concludes that, despite methodological shortcomings, both the original Good Friday experiment and this long-term follow-up provide convergent evidence that psilocybin given to religiously inclined individuals in a supportive religious setting can facilitate experiences that the subjects judge to be mystical and that such sessions can produce enduring positive changes in attitude and behaviour. The inability to maintain the double-blind limits claims that the effects were solely pharmacological; Doblin emphasises that Pahnke designed the study to maximise the combined impact of psilocybin and contextual suggestion rather than to isolate pure drug effects. The follow-up criticises aspects of the original reporting: the questionnaire contained some items (for example, items measuring mere loss of ordinary identity) that could inflate mystical scores, and Pahnke omitted reporting the administration of thorazine and underplayed the prevalence and intensity of difficult, fearsome experiences among psilocybin subjects. Doblin suggests these omissions contributed to an overly optimistic public narrative and, along with sensationalised media coverage, helped fuel the backlash against psychedelic research in the 1960s. Finally, Doblin argues that the rarity of enduring adverse outcomes in controlled studies and the persistent positive reports here support renewed, cautious research. He recommends multidisciplinary teams (psychiatrists, psychologists, religious professionals, and drug‑abuse specialists), careful attention to preparation and set/setting, and patience from regulators. The extracted text ends with an appeal that fundamental questions about psychedelic‑facilitated mystical experiences deserve scientific attention, balanced by the need for careful methodology and planning.